X4 Pharmaceuticals CEO Paula Ragan's 2022 pay jumps 81% to $3.9M
X4 Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 25, 2023
X4 Pharmaceuticals reported fiscal year 2022 executive compensation information on April 25, 2023.
In 2022, three executives at X4 Pharmaceuticals received on average a compensation package of $2.5M, a 68% increase compared to previous year.
Average pay of disclosed executives at X4 Pharmaceuticals
Paula Ragan, Chief Executive Officer, received $3.9M in total, which increased by 81% compared to 2021. 63% of Ragan's compensation, or $2.4M, was in option awards. Ragan also received $59K in bonus, $309K in non-equity incentive plan, $583K in salary, $477K in stock awards, as well as $13K in other compensation.
Adam S. Mostafa, Chief Financial Officer, received a compensation package of $1.9M, which increased by 40% compared to previous year. 51% of the compensation package, or $955K, was in option awards.
Mary DiBiase, Chief Operating Officer, earned $1.8M in 2022.
Related executives
You may also like
Source: SEC filing on April 25, 2023.